Catanzarite V, Quirk J G, Aisenbrey G
Department of Obstetrics and Gynecology, University of Arkansas Medical Center, Little Rock.
Am J Perinatol. 1991 Jan;8(1):7-10. doi: 10.1055/s-2007-999327.
The members of the Society of Perinatal Obstetricians were surveyed regarding management of preeclampsia, with focus on drug therapy, use of invasive monitors, and both general policies and treatment of hypothetical cases of preterm severe preeclampsia. There was agreement that magnesium sulfate should be given to all patients with preeclampsia during labor and postpartum and that blood pressure should be held to about 160/105 mmHg. The drugs of choice for control of blood pressure were hydralazine, alpha-methyldopamine, and cardioselective beta-blockers. Most perinatologists use invasive monitors only for specific indications, but a substantial minority use either arterial lines or central venous pressure monitors routinely in severe preeclampsia. There was no consensus with respect to management of preterm, severe preeclampsia, but even among the 49% of respondents who volunteered an unequivocal policy of "deliver regardless of gestational age," over three fourths would hospitalize and observe in selected cases meeting American College of Obstetrics and Gynecology criteria for severe preeclampsia.
围产期产科医生协会的成员接受了关于子痫前期管理的调查，重点是药物治疗、侵入性监测仪的使用，以及早产重度子痫前期的一般政策和假设病例的治疗。大家一致认为，分娩期间和产后应给所有子痫前期患者使用硫酸镁，血压应控制在约160/105 mmHg。控制血压的首选药物是肼屈嗪、α-甲基多巴和心脏选择性β受体阻滞剂。大多数围产医学专家仅在特定指征下使用侵入性监测仪，但有相当一部分人在重度子痫前期常规使用动脉导管或中心静脉压监测仪。对于早产重度子痫前期的管理没有达成共识，但即使在49%明确表示“无论孕周大小均进行分娩”的受访者中，超过四分之三的人会在符合美国妇产科医师学会重度子痫前期标准的特定病例中收住院观察。
